Niresh Hariparsad

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Cross Sectional

Epidermal Growth Factor Receptor

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical and translational science

Journal of medicinal chemistry

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Krishna C Aluri, Marina Slavsky, Ying Tan, Andrea Whitcher-Johnstone, Zhoupeng Zhang, Niresh Hariparsad, Diane Ramsden
Aminobenzotriazole inhibits and induces several key drug metabolizing enzymes complicating its utility as a pan CYP inhibitor for reaction phenotyping. Clinical and translational science 17 (3) (2024)
Adelphe M Mfuh, Jeffrey A Boerth, Gayathri Bommakanti, Christina Chan, Alex J Chinn, Erin Code, Patrick J Fricke, Kathryn A Giblin, Andrea Gohlke, Catherine Hansel, Niresh Hariparsad, Samantha J Hughes, Meizhong Jin, Vasudev Kantae, Stefan L Kavanagh, Michelle L Lamb, Jordan Lane, Rachel Moore, Taranee Puri, Taylor R Quinn, Iswarya Reddy, Graeme R Robb, Kevin J Robbins, Miguel Gancedo Rodrigo, Marianne Schimpl, Baljinder Singh, Meha Singh, Haoran Tang, Clare Thomson, Jarrod J Walsh, Jamie Ware, Iain D G Watson, Min-Wei Ye, Gail L Wrigley, Andrew X Zhang, Yun Zhang, Neil P Grimster
Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors. Journal of medicinal chemistry 67 (2) (2024)
Krishna C Aluri, Marina Slavsky, Ying Tan, Andrea Whitcher-Johnstone, Zhoupeng Zhang, Niresh Hariparsad, Diane Ramsden
Aminobenzotriazole inhibits and induces several key drug metabolizing enzymes complicating its utility as a pan CYP inhibitor for reaction phenotyping. Clinical and translational science 17 (3) (2024)
Adelphe M Mfuh, Jeffrey A Boerth, Gayathri Bommakanti, Christina Chan, Alex J Chinn, Erin Code, Patrick J Fricke, Kathryn A Giblin, Andrea Gohlke, Catherine Hansel, Niresh Hariparsad, Samantha J Hughes, Meizhong Jin, Vasudev Kantae, Stefan L Kavanagh, Michelle L Lamb, Jordan Lane, Rachel Moore, Taranee Puri, Taylor R Quinn, Iswarya Reddy, Graeme R Robb, Kevin J Robbins, Miguel Gancedo Rodrigo, Marianne Schimpl, Baljinder Singh, Meha Singh, Haoran Tang, Clare Thomson, Jarrod J Walsh, Jamie Ware, Iain D G Watson, Min-Wei Ye, Gail L Wrigley, Andrew X Zhang, Yun Zhang, Neil P Grimster
Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors. Journal of medicinal chemistry (2024)
Christina Vasalou, Theresa A Proia, Laura Kazlauskas, Anna Przybyla, Matthew Sung, Srinivas Mamidi, Kim Maratea, Matthew Griffin, Rebecca Sargeant, Jelena Urosevic, Anton I Rosenbaum, Jiaqi Yuan, Krishna C Aluri, Diane Ramsden, Niresh Hariparsad, Rhys D O Jones, Jerome T Mettetal
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Christina Vasalou, Theresa A Proia, Laura Kazlauskas, Anna Przybyla, Matthew Sung, Srinivas Mamidi, Kim Maratea, Matthew Griffin, Rebecca Sargeant, Jelena Urosevic, Anton I Rosenbaum, Jiaqi Yuan, Krishna C Aluri, Diane Ramsden, Niresh Hariparsad, Rhys D O Jones, Jerome T Mettetal
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Krishna C Aluri, Marina Slavsky, Ying Tan, Andrea Whitcher-Johnstone, Zhoupeng Zhang, Niresh Hariparsad, Diane Ramsden
Aminobenzotriazole inhibits and induces several key drug metabolizing enzymes complicating its utility as a pan CYP inhibitor for reaction phenotyping. Clinical and translational science 17 (3) (2024)
Christina Vasalou, Theresa A Proia, Laura Kazlauskas, Anna Przybyla, Matthew Sung, Srinivas Mamidi, Kim Maratea, Matthew Griffin, Rebecca Sargeant, Jelena Urosevic, Anton I Rosenbaum, Jiaqi Yuan, Krishna C Aluri, Diane Ramsden, Niresh Hariparsad, Rhys D O Jones, Jerome T Mettetal
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression. CPT: pharmacometrics & systems pharmacology (2024)
Christina Vasalou, Theresa A Proia, Laura Kazlauskas, Anna Przybyla, Matthew Sung, Srinivas Mamidi, Kim Maratea, Matthew Griffin, Rebecca Sargeant, Jelena Urosevic, Anton I Rosenbaum, Jiaqi Yuan, Krishna C Aluri, Diane Ramsden, Niresh Hariparsad, Rhys D O Jones, Jerome T Mettetal
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Adelphe M Mfuh, Jeffrey A Boerth, Gayathri Bommakanti, Christina Chan, Alex J Chinn, Erin Code, Patrick J Fricke, Kathryn A Giblin, Andrea Gohlke, Catherine Hansel, Niresh Hariparsad, Samantha J Hughes, Meizhong Jin, Vasudev Kantae, Stefan L Kavanagh, Michelle L Lamb, Jordan Lane, Rachel Moore, Taranee Puri, Taylor R Quinn, Iswarya Reddy, Graeme R Robb, Kevin J Robbins, Miguel Gancedo Rodrigo, Marianne Schimpl, Baljinder Singh, Meha Singh, Haoran Tang, Clare Thomson, Jarrod J Walsh, Jamie Ware, Iain D G Watson, Min-Wei Ye, Gail L Wrigley, Andrew X Zhang, Yun Zhang, Neil P Grimster
Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors. Journal of medicinal chemistry 67 (2) (2024)
Christina Vasalou, Theresa A Proia, Laura Kazlauskas, Anna Przybyla, Matthew Sung, Srinivas Mamidi, Kim Maratea, Matthew Griffin, Rebecca Sargeant, Jelena Urosevic, Anton I Rosenbaum, Jiaqi Yuan, Krishna C Aluri, Diane Ramsden, Niresh Hariparsad, Rhys D O Jones, Jerome T Mettetal
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Srinivasan Krishnan, Diane Ramsden, Douglas Ferguson, Simone H Stahl, Joanne Wang, Dermot F McGinnity, Niresh Hariparsad
Challenges and Opportunities for Improved Drug-Drug Interaction Predictions for Renal OCT2 and MATE1/2-K Transporters. Clinical pharmacology and therapeutics 112 (3) (2022)